UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
December 7, 2020
Accession Number:
0001564590-20-055771
Submission Type:
POS AM
CIK:
0001351172
Company Name:
Liminal BioSciences Inc.
File Number:
333-245703